Related Experiment Video
Updated: Jul 23, 2025

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
Krisztián Szegedi1,2, Zsuzsanna Szabó3, Judit Kállai4
1Department of Urology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Abstract:
The genetic profiling of renal tumors has revealed genomic regions commonly affected by structural changes and a general genetic heterogeneity. The VHL, PTEN, and BAP1 genes are often mutated in renal tumors. The frequency and clinical relevance of these mutations in renal tumors are still being researched. In our study, we investigated VHL, PTEN, and BAP1 genes and the sequencing of 24 samples of patients with renal tumors, revealing that VHL was mutated at a noticeable frequency (25%). Six of the investigated samples showed mutations, and one genetic polymorphism (rs779805) was detected in both heterozygote and homozygote forms. PTEN gene mutation was observed in only one sample, and one specimen showed genetic polymorphism. In the case of the BAP1 gene, all of the samples were wild types. Interestingly, VHL mutation was detected in two female patients diagnosed with AML and in one with oncocytoma. We assume that VHL or PTEN mutations may contribute to the development of human renal cancer. However, the overall mutation rate was low in all specimens investigated, and the development and prognosis of the disease were not exclusively associated with these types of genetic alterations.
Insights
Genetic analysis of renal tumors revealed VHL gene mutations in 25% of samples, suggesting a potential role in renal cancer development. However, overall mutation rates were low, indicating complex genetic factors influence disease progression.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Renal tumors exhibit genetic heterogeneity with common structural changes.
- Mutations in VHL, PTEN, and BAP1 genes are frequently observed in renal tumors.
- The clinical significance of these mutations requires further investigation.
Purpose of the Study:
- To investigate the mutation frequency and clinical relevance of VHL, PTEN, and BAP1 genes in a cohort of renal tumor patients.
- To identify potential genetic markers associated with renal tumor development.
Main Methods:
- DNA sequencing of 24 renal tumor samples.
- Analysis of mutations and genetic polymorphisms in VHL, PTEN, and BAP1 genes.
Main Results:
- VHL gene mutations were detected in 25% of samples, with specific instances in AML and oncocytoma.
- PTEN gene mutations were rare (one sample), and BAP1 showed no mutations (all wild-type).
- One genetic polymorphism (rs779805) was identified in VHL.
Conclusions:
- VHL and PTEN mutations may contribute to human renal cancer development.
- The overall mutation rate for these genes was low, suggesting other genetic alterations are involved.
- Disease development and prognosis are not solely determined by VHL, PTEN, or BAP1 mutations.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

